Causes of Elevated Lithium Levels
Elevated serum lithium concentrations result primarily from impaired renal excretion due to drug interactions (particularly diuretics, ACE inhibitors, ARBs, and NSAIDs), decreased sodium intake or dehydration, reduced kidney function, and acute intercurrent illnesses.
Primary Mechanisms
Drug Interactions
The most clinically significant cause of elevated lithium levels involves medications that reduce renal clearance. 1, 2, 3
- Diuretics (especially thiazides): Cause sodium depletion, leading to increased proximal tubular reabsorption of lithium
- ACE inhibitors and ARBs: Reduce glomerular filtration rate and lithium clearance 1, 4
- NSAIDs: Significantly increase steady-state lithium concentrations by reducing renal blood flow and GFR. Indomethacin and piroxicam are particularly problematic 3, 5
- Aldosterone antagonists (spironolactone, eplerenone): Associated with lithium toxicity when used concomitantly 1
- Antibiotics: Emerging evidence suggests antibiotics contribute substantially to elevated lithium levels 5
Sodium and Fluid Balance
Lithium excretion parallels sodium excretion—any condition causing sodium depletion will elevate lithium levels. 3, 6
- Decreased sodium intake: Reduction from 6.3 g/day to 3.0-4.0 g/day can elevate lithium from therapeutic to toxic range 6
- Dehydration: From any cause (fever, sweating, diarrhea, vomiting) 3, 7
- Protracted sweating or diarrhea: Requires supplemental fluid and salt 3
Renal Dysfunction
Impaired kidney function directly reduces lithium clearance, as lithium is primarily renally excreted. 2
- Chronic kidney disease (GFR <60 mL/min/1.73 m²) increases toxicity risk
- Acute kidney injury from any cause
- Pre-renal azotemia 8
Metabolic and Endocrine Factors
Thyrotoxicosis can precipitate lithium toxicity by increasing tubular reabsorption of lithium. 7
- Silent thyroiditis or other causes of acute thyrotoxicosis
- Thyroid hormone increases tubular lithium reabsorption, reducing clearance
Patient-Related Factors
Older age is independently associated with slower lithium clearance. 4
- Elderly patients have reduced renal function and total body water
- Higher serum sodium concentrations paradoxically predict slower lithium clearance 4
Clinical Context
Acute Intercurrent Illness
Any serious illness that increases AKI risk requires temporary discontinuation of lithium in patients with GFR <60 mL/min/1.73 m². 2
Medication Adherence Issues
Irregular lithium dispensing patterns are associated with elevated levels. 5
- Paradoxically, discontinuation followed by resumption can lead to toxicity if renal function is compromised 7
Important Caveats
- Lithium toxicity can occur at therapeutic levels in sensitive patients or with rapid changes in clinical status 3
- Monitor lithium levels more frequently (not just every 6 months) when dose changes, during acute illness, or when starting potentially interacting medications 2
- Maintain adequate hydration (2500-3000 mL daily) and normal salt intake during lithium therapy 3
- Check thyroid function immediately in patients with suspected lithium toxicity, as thyrotoxicosis may be contributory 7
Drug Interaction Pitfall
The combination of NSAIDs + lithium is particularly dangerous and should be avoided 2, 3. If unavoidable, close monitoring is mandatory. Similarly, the triple combination of diuretic + ACE inhibitor/ARB + lithium creates compounded risk 1, 2.